REPR | tickerfilter.com

Fundamental analysis

59%

Profitability 93%

Dept financing 6%

Liquidity 75%

Performance 34%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0 0%

1 Month

0 0%

3 Months

0 0%

6 Months

0 0%

1 Year

0 0%

2 Year

0 0%

Key data

Stock price

$4.00

P/E Ratio

N/A

DAY RANGE

$4.00 - $4.00

EPS

$0.00

52 WEEK RANGE

$1.35 - $4.25

52 WEEK CHANGE

$173.97

MARKET CAP

153.536 M

YIELD

N/A

SHARES OUTSTANDING

38.384 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

$22,144,689

AVERAGE 10 VOLUME

$62,624

AVERAGE 30 VOLUME

$38,837

Company detail

CEO: Donald B. Pettigrew
Region: US
Website: http://www.rmsmedicalproducts.com
Employees: 76
IPO year: -

Issue type: Common Stock
Market: NASDAQ
Industry: Medical Specialties
Sector: Health Technology

Repro-Med Systems, Inc.engages in the design, manufacture, and market of proprietary medical devices. It products include FREEDOM60, a syringe infusion pump, which is designed for ambulatory medication infusions; HIgH-Flo, is designed for self-administration of medicine under the skin; and RES-Q-VAC, is a portable and hand-operated suction device that removes fluids from a patients airway. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Chester, NY.

REPR - REPRO-MED Systems Inc.